SMTL ID : 7t4i.1

Crystal Structure of wild type EGFR in complex with TAK-788

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.61 Å

Oligo State

monomer

Ligands

1 x R28: propan-2-yl 2-[[4-[2-(dimethylamino)ethyl-methyl-amino]-2-methoxy-5-(propanoylamino)phenyl]amino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate(Covalent)

R28.1: 14 residues within 4Å: Chain A: L.24, F.29, V.32, A.49, T.96, Q.97, L.98, M.99, P.100, G.102, C.103, D.106, E.110, L.150 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.24, A:F.29, A:V.32, A:T.96, A:L.150 Hydrogen bonds: A:T.96, A:M.99, A:M.99, A:C.103 Salt bridges: A:D.106, A:E.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, W.S. et al., Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancer. Bioorg.Med.Chem.Lett. (2022)

Release Date

2022-12-07

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence